Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity-Reference-Cited by-同舟云学术

Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity

Published:2024-05-22 Issue:6 Volume:44 Page:
ISSN:0271-9142
Container-title:Journal of Clinical Immunology
language:en
Short-container-title:J Clin Immunol

Author:

Miyamoto Satoshi,Niizato Daiki,Tomomasa Dan,Nishimura Akira,Hoshino Akihiro,Kamiya Takahiro,Isoda Takeshi,Takagi Masatoshi,Kajiwara Michiko,Azumi Shohei,Hirabayashi Shinsuke,Sakamoto Kenichi,Kishimoto Kenji,Miyamura Takako,Umeda Katsutsugu,Hirose Ayana,Keino Dai,Yanagimachi Masakatsu,Kanda Kaori,Sakai Yuta,Ikawa Yasuhiro,Watanabe Kenichiro,Tanaka Keisuke,Mori Takehiko,Ichinohe Tatsuo,Sakaguchi Hirotoshi,Morio Tomohiro,Kanegane Hirokazu

Funder

MEXT/JSPS KAKENHI

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10875-024-01734-5.pdf

Reference26 articles.

1. Guilcher GMT, Shah R, Shenoy S. Principles of alemtuzumab immunoablation in hematopoietic cell transplantation for non-malignant diseases in children: a review. Pediatr Transpl. 2018;22(2).

2. Tomizawa D, Miyamura T, Imamura T, Watanabe T, Saito AM, Ogawa A, et al. A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial. Blood. 2020;136(16):1813–23.

3. Kawaguchi K, Umeda K, Miyamoto S, Yoshida N, Yabe H, Koike T, et al. Graft-versus-host disease-free, relapse-free, second transplant-free survival in allogeneic hematopoietic cell transplantation for genetic disorders. Bone Marrow Transpl. 2023;58(5):600–2.

4. Kanda Y. Investigation of the freely available easy-to-use software EZR for medical statistics. [Internet]. Bone Marrow Transplantation; 2013 p. 452–8. (Bone Marrow Transplantation). http://www.nature.com/articles/bmt2012244.

5. Takashima T, Okamura M, Yeh T, wen, Okano T, Yamashita M, Tanaka K, et al. Multicolor Flow Cytometry for the diagnosis of primary Immunodeficiency diseases. J Clin Immunol. 2017;37(5):486–95.